SR
Highly rated in
31
conditions
Highly rated in
31
conditions
Check Dr. Sowjanya Reganti's experience treating your condition:
About Dr. Sowjanya Reganti

Sowjanya Reganti is a Hematologist Oncology expert in Reno, Nevada. Reganti has been practicing medicine for over 22 years and is highly rated in 31 conditions, according to our data. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Stomach Cancer, and Lung Cancer. She is licensed to treat patients in Nevada. Reganti is currently accepting new patients.

Her clinical research consists of co-authoring 2 peer reviewed articles and participating in 2 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Sowjanya Reganti it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
Locations
5423 Reno Corporate Dr., Reno, NV 89511
Background & Education
Graduate Institution
Other, 2000
Specialties
Hematology Oncology
Licenses
Internal Medicine in NV
Hospital Affiliations
Renown Regional Medical Center
Barton Memorial Hospital
Renown South Meadows Medical Center
Carson Tahoe Regional Medical Center
Banner Lassen Medical Center
Saint Marys Regional Medical Center
Northern Nevada Medical Center
Banner Churchill Community Hospital
Carson Valley Medical Center
Languages Spoken
English
Hindi
Spanish
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


2 Clinical Trials

A Randomized Phase III Post-operative Trial of Platinum Based Chemotherapy vs. Capecitabine in Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
View 1 Less Clinical Trial -

2 Total Publications

Combination dabrafenib and trametinib versus combination nivolumab and ipilimumab for patients with advanced BRAF-mutant melanoma: The DREAMseq Trial - ECOG-ACRIN EA6134.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors